Study on cartridge based nucleic acid amplification test in children with Neurotuberculosis at RNT Medical College, Udaipur, Rajasthan, India
Keywords:CBNAAT, Cererospinal fluid, Gastric aspirate, Tubercular meningoencephalitis
Background: The aim was to determine utility of Cartridge based nucleic acid amplification test (CBNAAT) in diagnosis of mycobacterium tuberculosis in children with neurotuberculosis diagnosed on the basis of clinical evaluation, CSF findings and neuroimaging.
Methods: A prospective randomized controlled trial was conducted in Pediatric Department of RNT Medical College, Udaipur, Rajasthan, India from July 2017 to June 2018. Total 110 children of age group of 6 months to 18 years with the diagnosis of tubercular meningoencephalitis (TBME) on the basis of clinical evaluation, CSF examination and neuroimaging were included in the study.
Results: A total 110 children were enrolled. Maximum number of cases admitted with TBME were among 1-5 years of age group (60.91%). CSF and gastric aspirate were examined by CBNAAT for MTB. 5 (4.55%) children had CBNAAT positivity in CSF. Gastric aspirate was positive among 16 (14.55%) children. None of the patient had CBNAAT positive result both in CSF and gastric aspirate.
Conclusions: TBME is a major health problem in children below 5 years. Gene Xpert assay has the potential to significantly improve and escalate the diagnosis of smear-negative body fluid specimens. CBNAAT for mycobacterium tuberculosis was positive in 5 (4.55%) children from CSF and 16 (14.55%) from gastric aspirate. Negative CBNAAT should not prevent any patient with suspected features of TBME from starting anti tubercular treatment (ATT) as sensitivity of this test remains low. Final judgement to start ATT should be based on clinical, biochemical and radiological profile especially in CNS tuberculosis.
WHO. Global Tuberculosis Report. 2018;1-7.
Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N. The burden of childhood tuberculosis and the accuracy of community-based surveillance data. Int J Tuberc Lung Dis. 2006;10(3):259-63.
Boehme CC, Nabeta P, Hillmann D. Rapid molecular detection of tuberculosis and rifampicin resistance. N Eng J Med. 2010; 363(11):1005-15.
Garg RK. Tuberculosis of the central nervous system. Postgrad Med J. 1999;75(881):13-140.
Hosoglu S, Geyik MF, Balik. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis. 2002;6(1):64-70.
Lawn SD, Brooks SV, Kranzer K. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011;8(7):e1001067.
Helb D, Jones M, Story E. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance by use of on-demand, near patient technology. J Clin Microbiol. 2010; 48(1):229-37.
Rie AV, Shipp PL, Scott L, Sanne I, Stevens W. Xpert MTB/RIF for point of care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?. Expert Rev Mol Diag. 2010;10(7):937-46.
Singh R, Shetty N, Naveed M. Clinical profile of pediatric neurotuberculosis patients at a tertiary care center of Western India. Muller J Med Sci Res. 2018;9(1):12-15.
Avashia S, Bansal D, Ahuja K, Agrawal V. Comparison of conventional methods with gene Xpert MTB/RIF assay for rapid detection of mycobacterium tuberculosis and rifampicin resistance in extra-pulmonary samples. Int J Med Res Rev. 2016;4(2):181-5.
Moure R, Martín R, Alcaide F. Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence. J Clin Microbiol. 2012;50(2):513-5.
Singh A, Shukla AK, Kaur R. Role of CBNAAT in diagnosis of Tuberculous Meningitis. Int J Curr Res Med Sci. 2018;4(2):59-65.
Udani PM. Neurotuberculosis. In: Seth V, Kabra SK, eds. Essentials of Tuberculosis in Children. 4th ed. Jaypee Brothers Publishers; 2011: 150-180.